BioOra
Chemicals & Related Products · New Zealand · 1-10 Employees
View Company Info for Free
Overview
Headquarters
38 Waring Taylor St L 1, Wellington, Wel...Website
www.bioora.comRevenue
<$5 MillionIndustry
About BioOra
BioOra Org Chart
Is BioOra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BioOra, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BioOra recently announced quarterly report
Click to see if BioOra had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioOra
Funding: Get notified immidiatlly once BioOra has new funding data
Check out if BioOra is spiking on competitors!
Product Launch: Get notified when BioOra launches new products
Check if BioOra has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
BioOra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioOra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioOra.
BioOra Tech Stack
A closer look at the technologies used by BioOra
BioOra News & Media
BioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemia
BioOra and Cincinnati Children's unite to evaluate Atla-cel in paediatric relapsed or refractory B-ALL, building on emerging adult clinical data demonstrating markedly reduced neurotoxicity with this next-generation CAR-T therapy. Key Takeaways: BioOra and Cincinnati Children's are...BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international markets Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international marketsPhase 1 CD-19 specific third generation CAR T cell study data supports use of BioOra’s automated manufacture for phase 2
BioOra’s automated CAR T cell platform will be used in an upcoming Phase 2 efficacy trial. SAN DIEGO, CALIFORNIA, UNITED STATES, December 11, 2023 /EINPresswire.com/ -- Results from 25 patients with relapsed or refractory B-cell non-Hodgkin lymphomas on …BioOra Appoints Cell Therapy Pioneer, Professor Carl June to Board of Directors
WELLINGTON, NEW ZEALAND, October 31, 2023 /EINPresswire.com/ -- BioOra, a biopharma joint venture between the Malaghan Institute of Medical Research and Bridgewest Ventures, has appointed Carl June, MD to its Board of Directors. Carl June is globally …
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BioOra
BioOra is dedicated to automating the manufacture of CAR T-cells, aiming to enhance access and efficiency in cell therapy manufacturing for cancer treatment. The company utilizes a semi-automated GMP platform to streamline the complex and resource-intensive process of CAR T-cell production, allowing for rapid scaling and consistent quality. Current... Read More